Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vaxart, Inc. | 75,000 | reported | 18 May 2017 | tx 3+75,000 |
| SCYNEXIS INC | 71,000 | reported | 26 Jun 2025 | tx 16+367,000 |
| AUXILIUM PHARMACEUTICALS INC | 13,653 | reported | 07 Oct 2011 | tx 58+1,701,440−541,519 |
| MEDIMMUNE INC /DE | 8,659 | reported | 03 Feb 2006 | tx 7+81,562−23,124 |
| Zynerba Pharmaceuticals, Inc. | 0 | reported | 10 Oct 2023 | tx 33+2,410,582−1,571,069 |
| ADOLOR CORP | 0 | reported | 07 Dec 2011 | tx 26+360,450−310,450 |
| NUPATHE INC. | 0 | reported | 21 Feb 2014 | tx 7+2,008,190−2,008,190 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jun 2025 | GRANT_AWARD | SCYNEXIS INC | 23,000 | 0.00 USD | |
| 26 Jun 2025 | GRANT_AWARD | SCYNEXIS INC | 23,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | SCYNEXIS INC | 23,000 | 0.00 USD | |
| 20 Jun 2024 | GRANT_AWARD | SCYNEXIS INC | 23,000 | 0.00 USD | deriv |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 566,722 | — | |
| 10 Oct 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 240,000 | — | |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 610,000 | — | |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 26,595 | — | |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 13,297 | — | |
| 10 Oct 2023 | OTHER | Zynerba Pharmaceuticals, Inc. | 190,000 | — | deriv |
| 13 Sept 2023 | SALE | Zynerba Pharmaceuticals, Inc. | 17,830 | 1.33 USD | |
| 12 Sept 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 64,747 | — | |
| 15 Jun 2023 | GRANT_AWARD | SCYNEXIS INC | 10,000 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | SCYNEXIS INC | 10,000 | 0.00 USD | deriv |
| 07 Feb 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 45,406 | — | |
| 08 Feb 2023 | TAX_WITHHOLDING | Zynerba Pharmaceuticals, Inc. | 12,547 | 0.60 USD | |
| 01 Feb 2023 | TAX_WITHHOLDING | Zynerba Pharmaceuticals, Inc. | 11,726 | 0.60 USD | |
| 31 Jan 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 42,437 | — | |
| 23 Jan 2023 | SALE | Zynerba Pharmaceuticals, Inc. | 35,453 | 0.60 USD | anomaly |
| 24 Jan 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 250,000 | 0.00 USD | |
| 19 Jul 2022 | SALE | Zynerba Pharmaceuticals, Inc. | 11,899 | 1.10 USD | anomaly |
| 18 Jul 2022 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 43,164 | — | |
| 17 Jun 2022 | GRANT_AWARD | SCYNEXIS INC | 10,000 | 0.00 USD | |
| 17 Jun 2022 | GRANT_AWARD | SCYNEXIS INC | 10,000 | 0.00 USD | deriv |
| 26 Jan 2022 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 120,000 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 21 Dec 2020.